These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31895174)

  • 1. Sublingual Versus Swallowed Morphine: A Comparison.
    Dyal BW; Powell-Roach KL; Robison J; Campbell B; Yoon SL; Wilkie DJ
    Cancer Nurs; 2021; 44(1):E13-E22. PubMed ID: 31895174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.
    Shimoyama N; Gomyo I; Teramoto O; Kojima K; Higuchi H; Yukitoshi N; Ohta E; Shimoyama M
    Jpn J Clin Oncol; 2015 Feb; 45(2):189-96. PubMed ID: 25378647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual and oral morphine administration. Review and new findings.
    Robison JM; Wilkie DJ; Campbell B
    Nurs Clin North Am; 1995 Dec; 30(4):725-43. PubMed ID: 7501539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral morphine for cancer pain.
    Wiffen PJ; Wee B; Moore RA
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003868. PubMed ID: 27105021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine for treating cancer pain.
    Schmidt-Hansen M; Bromham N; Taubert M; Arnold S; Hilgart JS
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009596. PubMed ID: 25826743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral morphine for cancer pain.
    Wiffen PJ; Wee B; Moore RA
    Cochrane Database Syst Rev; 2013 Jul; (7):CD003868. PubMed ID: 23881654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain.
    Velázquez Rivera I; Muñoz Garrido JC; García Velasco P; España Ximénez de Enciso I; Velázquez Clavarana L
    Adv Ther; 2014 Jan; 31(1):107-17. PubMed ID: 24385406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain.
    De Conno F; Ripamonti C; Saita L; MacEachern T; Hanson J; Bruera E
    J Clin Oncol; 1995 Apr; 13(4):1004-8. PubMed ID: 7707099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual morphine: efficacy reviewed.
    Coluzzi PH
    J Pain Symptom Manage; 1998 Sep; 16(3):184-92. PubMed ID: 9769621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
    Rauck R; Reynolds L; Geach J; Bull J; Stearns L; Scherlis M; Parikh N; Dillaha L
    Curr Med Res Opin; 2012 May; 28(5):859-70. PubMed ID: 22480131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study.
    Sloan P; Slatkin N; Ahdieh H
    Support Care Cancer; 2005 Jan; 13(1):57-65. PubMed ID: 15538638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.
    Shimoyama N; Gomyo I; Katakami N; Okada M; Yukitoshi N; Ohta E; Shimoyama M
    Int J Clin Oncol; 2015 Feb; 20(1):198-206. PubMed ID: 24839047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer.
    Davis T; Miser AW; Loprinzi CL; Kaur JS; Burnham NL; Dose AM; Ames MM
    Hosp J; 1993; 9(1):85-90. PubMed ID: 8406404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial.
    Melson TI; Boyer DL; Minkowitz HS; Turan A; Chiang YK; Evashenk MA; Palmer PP
    Pain Pract; 2014 Nov; 14(8):679-88. PubMed ID: 25155134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial.
    Ricchini F; Caraceni A; Zecca E; Pigni A; Centurioni F; Manzoni A; Kaasa S; Brunelli C
    J Pain Symptom Manage; 2019 Oct; 58(4):587-595. PubMed ID: 31233843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premedication with sublingual morphine sulphate in abdominal surgery.
    Campiglia L; Cappellini I; Consales G; Borracci T; Vitali L; Gallerani E; Boninsegni P; Domenico Mediati R; Raffaele De Gaudio A
    Clin Drug Investig; 2009; 29 Suppl 1():25-30. PubMed ID: 19445552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.
    Lennernäs B; Hedner T; Holmberg M; Bredenberg S; Nyström C; Lennernäs H
    Br J Clin Pharmacol; 2005 Feb; 59(2):249-53. PubMed ID: 15676050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.